DH

Doug Hughes

Chief Financial Officer at Calyxo

Doug Hughes has a diverse work experience spanning over 25 years. Doug is currently serving as the Chief Financial Officer at Calyxo, Inc. since October 2019.

Prior to their current role, Doug worked as the Chief Financial Officer at NeoTract, Inc. from 2011 to April 2018. During their tenure, they played a crucial role in introducing groundbreaking technology in the urology space and overseeing the successful launch and exponential growth of the company's product, UroLift, which achieved global revenues of approximately $290M in 2019.

Before NeoTract, Doug worked as the Chief Financial and Chief Operating Officer at Nellix Endovascular in 2010, where they were responsible for developing the company's European commercialization strategy and leading Endologix merger-related workstreams. Nellix Endovascular was later purchased by Endologix in December 2010.

From 2009 to 2010, Doug held the position of Chief Financial Officer at Evalve, Inc., a late-stage medical device start-up focused on the development of devices for minimally invasive repair of mitral valves. In this role, they collaborated with sales and operations to drive significant revenue growth.

Prior to Evalve, Doug served as the Chief Financial Officer at Maquet Cardiovascular in 2008, where they provided financial leadership and led the company's integration efforts to establish a stand-alone infrastructure after transitioning from Boston Scientific.

Doug's professional journey began at Guidant Corporation in 2003, where they served as the Vice President of Investor Relations. During their time at Guidant, they implemented an award-winning investor relations program, enhanced communications with Wall Street, and provided competitive insights to management.

Before Guidant, Doug worked at The Clorox Company for ten years, holding various roles including Director of Investor Relations, Laundry Category Finance Manager, Manager of Business Development, and Latin America Category Finance Manager. In these positions, they managed comprehensive investor relations programs, implemented communication strategies, and increased the company's visibility with the investment community.

Overall, Doug Hughes has a proven track record of strategic financial leadership and successful collaborations with various business functions, contributing to the growth and success of the companies they have worked for throughout their career.

Doug Hughes has a Bachelor of Science degree in International Finance from San Francisco State University. Doug also holds an MBA degree in Marketing and Management from the University of Chicago. The specific start and end years of their education are not provided.

Links

Previous companies

Boston Scientific logo
The Clorox Company logo

Org chart

Sign up to view 2 direct reports

Get started